Bawang, Aya Azkiyyah B.
HRN: 23-76-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2024
AMPICILLIN 500MG (VIAL)
02/25/2024
03/03/2024
IV
310 Mg
Q 6 Hours
PCAP-C (dose Increased To 200 MkDay)
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes